Quick Links Market Events nanosonics.com under Investor Centre, Corporate Governance. Add to Watchlist. )+[a-z]{2,63}/i);}, failureMessage: "Value must not contain any URL's"});field11.add(Validate.Presence, {failureMessage:"This field is required"});field11.add(Validate.Length, {tooShortMessage:"Invalid length for field value", tooLongMessage: "Invalid length for field value", minimum: 4, maximum: 4});function handleFormSubmit(ele) { var submitButton = ele.querySelector('input[type=submit]'); var spinner = document.createElement('span'); spinner.setAttribute('class', 'loader'); submitButton.setAttribute('disabled', true); submitButton.style.cursor = 'wait'; submitButton.parentNode.appendChild(spinner); return true; }function resetSubmitButton(e){ var submitButtons = e.target.form.getElementsByClassName('submit-button'); for(var i=0;iNanosonics: Annual Report 2018.
Nanosonics Ltd Ord (NNCSF) Data is currently not available. Specialist designers for Financial Reporting, Corporate Communications, Investor Relations + M&A Transaction Documents.
We maintain our AUD 2.95 fair value estimate for narrow-moat Nanosonics following fiscal 2020 results and a transfer of analyst coverage. Nasdaq Data FULLSCREEN. Add to Portfolio. Touch device users, explore by touch or with swipe gestures.var dom1 = document.querySelector('#form1783 #field1');var field1 = new LiveValidation(dom1, {validMessage: "", onlyOnBlur: false, wait: 300});field1.add(Validate.Presence, {failureMessage:"This field is required"});field1.add(Validate.Format, {pattern: /^([^@\s]+)@((?:[-a-z0-9]+\. Nanosonics (ASX: NAN), a leader in infection control solutions, today released its Appendix 4D Half Yearly Report for the period ending 31 December 2015. nodes[i].dataset.subscription : nodes[i].getAttribute('data-subscription'); if(status ==='true') {nodes[i].checked = true;}}};var nodes = document.querySelectorAll('#form1783 select[data-value]'); if (nodes) { for (var i = 0; i < nodes.length; i++) { var node = nodes[i]; var selectedValue = node.dataset ? Nanosonics Limited ABN 11 095 076 896 14 Mars Road, Lane Cove NSW 2066 Australia Tel: +61 2 8063 1600 Fax: +61 2 8063 1600 Email: info@nanosonics.com.au w: www.nanosonics.com.au ... Investor conference call Investors are invited to join a conference call hosted by Michael Kavanagh, CEO and ... Investor Relations… SHARE. As at June 2020, there were 23,720 trophon units installed globally. Features H1 FY16 record sales of $15.577 million … Add to Portfolio. Shares continue to screen as overvalued. )+[a-z]{2,})$/i, failureMessage: "A valid email address is required"});var dom2 = document.querySelector('#form1783 #field2');var field2 = new LiveValidation(dom2, {validMessage: "", onlyOnBlur: false, wait: 300});field2.add(Validate.Presence, {failureMessage:"This field is required"});var dom11 = document.querySelector('#form1783 #field11');var field11 = new LiveValidation(dom11, {validMessage: "", onlyOnBlur: false, wait: 300});field11.add(Validate.Custom, {against: function(value) {return !value.match(/(telnet|ftp|https?):\/\/(?:[a-z0-9][a-z0-9-]{0,61}[a-z0-9]\.|[a-z0-9]\. Nanosonics: Annual Report 2018 Annual Reports. We cut our fiscal 2021 EBIT forecast by 39% but leave our long-term estimates broadly unchanged.
The near-term outlook remains challenged, given reduced healthcare procedures and limited hospital access for the company’s sales team. The publication noted the significant unmet patient … Despite favourable currency movements, pandemic restrictions affected fourth-quarter revenue and fiscal 2020 underlying EBIT fell 10% to AUD 12.3 million, 41% below our forecast of AUD 20.9 million.